Skip to main content
AI Market Summary
Loading market intelligence...

BrightSpire Capital, Inc. (BRSP) Stock Forecast 2025 - AI Price Prediction & Analysis


BrightSpire Capital, Inc. (BRSP) AI Stock Price Forecast & Investment Analysis

BrightSpire Capital, Inc. Stock Price Chart and Technical Analysis

Loading BrightSpire Capital, Inc. interactive price chart and technical analysis...

BrightSpire Capital, Inc. (BRSP) - Comprehensive Stock Analysis & Investment Research

Deep dive into BrightSpire Capital, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about BrightSpire Capital, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For BrightSpire Capital, Inc.: BrightSpire Capital, Inc. operates in the Real Estate & Construction sector, making it an emerging small-cap investment.

BrightSpire Capital, Inc. (Stock Symbol: BRSP) is a leading company in the Real Estate & Construction sector , specifically operating within the Real Estate Investment Trusts industry.

The organization employs approximately 7 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing BrightSpire Capital, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For BrightSpire Capital, Inc.: With $330M in annual revenue and -34.0% net margin, the company demonstrates developing profitability.

Annual Revenue: $330 million generating a -34.0% net profit margin .

Market Capitalization: $754 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 1.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for BrightSpire Capital, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For BrightSpire Capital, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for BrightSpire Capital, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: BrightSpire Capital, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For BrightSpire Capital, Inc.: Strong free cash flow generation demonstrates developing operational efficiency.

BrightSpire Capital, Inc. strategically competes in the highly dynamic Real Estate Investment Trusts marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $9 million annually, complemented by impressive -29.8% year-over-year cash flow growth.

The company maintains a healthy 61.2% gross margin, indicating strong pricing power and operational efficiency.

BrightSpire Capital, Inc. (BRSP) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for BrightSpire Capital, Inc. stock analysis.

Loading BrightSpire Capital, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into BrightSpire Capital, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if BrightSpire Capital, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For BrightSpire Capital, Inc.: With a P/E ratio of -6.58, the market sees the stock as potentially undervalued.

P/E Ratio -6.58x
P/B Ratio 0.77x
Market Cap $754M
Dividend Yield 12.83%
EPS $-0.21
Book Value/Share $7.68
Revenue/Share $2.60
FCF/Share $0.54
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently BrightSpire Capital, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For BrightSpire Capital, Inc.: An ROE of 1.3% indicates room for improvement in shareholder value creation.

ROE 1.3%
ROA 0.3%
ROIC 0.9%
Gross Margin 61.2%
Operating Margin 35.3%
Net Margin -34.0%
EBT Margin 48.2%
Tax Rate 5.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess BrightSpire Capital, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For BrightSpire Capital, Inc.: A current ratio of 3.67 indicates strong liquidity.

Current Ratio 3.67x
Quick Ratio 3.04x
D/E Ratio 2.01x
Financial Leverage 3.97x
Interest Coverage 6.0x
Working Capital $4249M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal BrightSpire Capital, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For BrightSpire Capital, Inc.: Free cash flow of $9M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $9M
Free Cash Flow $9M
OCF Growth YoY -29.8%
FCF Growth YoY -29.8%
FCF/Sales 2.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively BrightSpire Capital, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For BrightSpire Capital, Inc.: An asset turnover of 0.05x suggests room for improvement in asset utilization.

Asset Turnover 0.05x
Receivables Turnover 6.5x
Fixed Assets Turnover 13.1x
Days Sales Outstanding 56 days
Payables Period 40 days
Understanding Financial Statement Data

What these metrics mean: Key figures from BrightSpire Capital, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For BrightSpire Capital, Inc.: With annual revenue of $330M, BrightSpire Capital, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $330M
Operating Income $114M
SG&A Expense $18M
Cost of Goods Sold $39M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 85%
Cash & Short-term Investments 4%
Total Liabilities 75%
Short-term Debt 21%
Accounts Receivable 66%
Dividend & Shareholder Information
Dividends Per Share $0.68
Shares Outstanding 127M
Growth Metrics (YoY)
EPS Growth -17.7%

Latest BrightSpire Capital, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting BrightSpire Capital, Inc. (BRSP) stock price and investment outlook.

BrightSpire Capital, Inc. Competitors & Peer Analysis - Real Estate & Construction Sector

Comparative analysis of BrightSpire Capital, Inc. against industry peers and competitors in the Real Estate & Construction sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAT Unlock Forecast - 30 Days FREE Trial $1183M 15.0x 1.0x
ABR Unlock Forecast - 30 Days FREE Trial $1640M 8.5x 0.6x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3388M 17.5x 1.1x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3327M 17.2x 1.1x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4329M 22.3x 1.4x
ACR Unlock Forecast - 30 Days FREE Trial $175M 6.1x 0.4x
ACRE Unlock Forecast - 30 Days FREE Trial $287M 8.5x 0.6x
ACR-PC Unlock Forecast - 30 Days FREE Trial $186M 6.5x 0.4x
ACR-PD Unlock Forecast - 30 Days FREE Trial $164M 5.7x 0.4x
ADC Unlock Forecast - 30 Days FREE Trial $8201M 42.4x 1.4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $1965M 10.2x 0.3x
AGNC Unlock Forecast - 30 Days FREE Trial $11113M 13.3x 1.0x
AGNCL Unlock Forecast - 30 Days FREE Trial $26572M 31.7x 2.3x
AGNCM Unlock Forecast - 30 Days FREE Trial $26611M 31.8x 2.3x
AGNCN Unlock Forecast - 30 Days FREE Trial $27429M 32.7x 2.4x
AGNCO Unlock Forecast - 30 Days FREE Trial $27182M 32.4x 2.4x
AGNCP Unlock Forecast - 30 Days FREE Trial $26818M 32.0x 2.3x
AHR Unlock Forecast - 30 Days FREE Trial $7689M 282.1x 2.9x
AHT Unlock Forecast - 30 Days FREE Trial $26M -1.5x -0.1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $115M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $84M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $87M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $84M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $84M x x
AIV Unlock Forecast - 30 Days FREE Trial $812M 3.4x 13.1x
AKR Unlock Forecast - 30 Days FREE Trial $2644M 232.9x 1.2x
ALEX Unlock Forecast - 30 Days FREE Trial $1523M 20.8x 1.5x
ALX Unlock Forecast - 30 Days FREE Trial $1115M 30.4x 8.7x
AMH Unlock Forecast - 30 Days FREE Trial $11656M 22.7x 1.6x
AMH-PG Unlock Forecast - 30 Days FREE Trial $8591M 16.8x 1.2x
AMH-PH Unlock Forecast - 30 Days FREE Trial $9040M 17.6x 1.3x
AMT Unlock Forecast - 30 Days FREE Trial $84414M 28.7x 21.4x
APLE Unlock Forecast - 30 Days FREE Trial $2911M 16.6x 0.9x
ARE Unlock Forecast - 30 Days FREE Trial $8073M 55.8x 0.5x
ARI Unlock Forecast - 30 Days FREE Trial $1406M 10.2x 0.8x
ARR Unlock Forecast - 30 Days FREE Trial $1906M 29.5x 0.9x
ARR-PC Unlock Forecast - 30 Days FREE Trial $2350M 36.4x 1.1x
AVB Unlock Forecast - 30 Days FREE Trial $25174M 21.5x 2.1x
BDN Unlock Forecast - 30 Days FREE Trial $523M -5.2x 0.6x
BFS Unlock Forecast - 30 Days FREE Trial $779M 19.9x 2.5x
BFS-PD Unlock Forecast - 30 Days FREE Trial $514M 13.2x 1.6x
BFS-PE Unlock Forecast - 30 Days FREE Trial $543M 13.9x 1.7x
BHM Unlock Forecast - 30 Days FREE Trial $33M 41.9x 0.3x
BHR Unlock Forecast - 30 Days FREE Trial $183M -3.1x 0.9x
BHR-PB Unlock Forecast - 30 Days FREE Trial $1026M x 4.8x
BHR-PD Unlock Forecast - 30 Days FREE Trial $1263M x 6.0x
BMNM Unlock Forecast - 30 Days FREE Trial $23M 24.8x 1.0x
BNL Unlock Forecast - 30 Days FREE Trial $3376M 37.6x 1.2x
BRSP Unlock Forecast - 30 Days FREE Trial $754M -6.6x 0.8x
BRT Unlock Forecast - 30 Days FREE Trial $272M -37.6x 1.5x
BRX Unlock Forecast - 30 Days FREE Trial $7980M 24.0x 2.7x
BXMT Unlock Forecast - 30 Days FREE Trial $3522M 32.9x 1.0x
BXP Unlock Forecast - 30 Days FREE Trial $11345M 2366.0x 2.3x
CBL Unlock Forecast - 30 Days FREE Trial $1141M 9.1x 3.3x
CCI Unlock Forecast - 30 Days FREE Trial $38928M 36.6x 5.5x
CDP Unlock Forecast - 30 Days FREE Trial $3324M 21.2x 2.2x
CDR-PB Unlock Forecast - 30 Days FREE Trial $251M 2284.7x 43.0x
CDR-PC Unlock Forecast - 30 Days FREE Trial $234M 2126.3x 40.0x
CHCT Unlock Forecast - 30 Days FREE Trial $436M -220.9x 1.0x
CHMI Unlock Forecast - 30 Days FREE Trial $93M 8.7x 0.4x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $767M 71.8x 3.3x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $872M 81.7x 3.7x
CHTH Unlock Forecast - 30 Days FREE Trial $657M x 1.0x
CIM Unlock Forecast - 30 Days FREE Trial $1030M 18.5x 0.4x
CIMN Unlock Forecast - 30 Days FREE Trial $2045M 36.7x 0.8x
CIMO Unlock Forecast - 30 Days FREE Trial $2051M 36.9x 0.8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1771M 31.8x 0.7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $1899M 34.1x 0.7x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1743M 31.3x 0.7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1874M 33.7x 0.7x
CIO Unlock Forecast - 30 Days FREE Trial $281M -15.4x 0.5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1019M x 1.7x
CLDT Unlock Forecast - 30 Days FREE Trial $337M 38.6x 0.5x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $963M 110.2x 1.3x
CLPR Unlock Forecast - 30 Days FREE Trial $55M -10.4x -20.5x
CMCT Unlock Forecast - 30 Days FREE Trial $3M -0.1x 0.0x
CMRF Unlock Forecast - 30 Days FREE Trial $1565M 213.8x 0.9x
COLD Unlock Forecast - 30 Days FREE Trial $3643M -26.5x 1.2x
CPT Unlock Forecast - 30 Days FREE Trial $11135M 41.4x 2.5x
CSR Unlock Forecast - 30 Days FREE Trial $1094M 35.9x 1.5x
CTO Unlock Forecast - 30 Days FREE Trial $581M 41.8x 1.0x
CTO-PA Unlock Forecast - 30 Days FREE Trial $673M x 1.2x
CTRE Unlock Forecast - 30 Days FREE Trial $8150M 31.2x 2.0x
CUBE Unlock Forecast - 30 Days FREE Trial $8335M 23.5x 3.0x
CUZ Unlock Forecast - 30 Days FREE Trial $4250M 73.8x 0.9x
CXW Unlock Forecast - 30 Days FREE Trial $2001M 18.3x 1.4x
DEA Unlock Forecast - 30 Days FREE Trial $1010M 72.9x 0.8x
DEI Unlock Forecast - 30 Days FREE Trial $1954M 87.9x 1.0x
DHC Unlock Forecast - 30 Days FREE Trial $1136M -1.7x 0.7x
DHCNI Unlock Forecast - 30 Days FREE Trial $4061M -10.4x 2.4x
DLR Unlock Forecast - 30 Days FREE Trial $52448M 37.5x 2.3x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $7393M 5.3x 0.3x
DLR-PK Unlock Forecast - 30 Days FREE Trial $8240M 5.9x 0.4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $7072M 5.1x 0.3x
DOC Unlock Forecast - 30 Days FREE Trial $11578M 78.3x 1.5x
DRH Unlock Forecast - 30 Days FREE Trial $1900M 29.7x 1.2x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5191M 81.2x 3.3x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1988M 10.8x 3.4x
DX-PC Unlock Forecast - 30 Days FREE Trial $3785M 20.5x 6.5x
EARN Unlock Forecast - 30 Days FREE Trial $194M -11.6x 0.9x
EGP Unlock Forecast - 30 Days FREE Trial $9789M 39.4x 2.8x
ELME Unlock Forecast - 30 Days FREE Trial $1529M -114.5x 1.7x
ELS Unlock Forecast - 30 Days FREE Trial $12157M 20.4x 6.9x
EPR Unlock Forecast - 30 Days FREE Trial $3842M 19.3x 1.9x
EPR-PC Unlock Forecast - 30 Days FREE Trial $1736M 8.7x 0.8x
EPR-PE Unlock Forecast - 30 Days FREE Trial $2301M 11.5x 1.1x
EPR-PG Unlock Forecast - 30 Days FREE Trial $1558M 7.8x 0.8x
EPRT Unlock Forecast - 30 Days FREE Trial $6095M 25.4x 1.6x
EQIX Unlock Forecast - 30 Days FREE Trial $74758M 69.8x 5.3x
EQR Unlock Forecast - 30 Days FREE Trial $23251M 20.1x 2.1x
ESBA Unlock Forecast - 30 Days FREE Trial $1849M 31.0x x
ESRT Unlock Forecast - 30 Days FREE Trial $1898M 54.4x 1.8x
ESS Unlock Forecast - 30 Days FREE Trial $16697M 19.7x 3.0x
EXR Unlock Forecast - 30 Days FREE Trial $28293M 29.8x 2.1x
FBRT Unlock Forecast - 30 Days FREE Trial $887M 9.3x 0.6x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1780M 18.7x 1.2x
FCPT Unlock Forecast - 30 Days FREE Trial $2431M 22.3x 1.6x
FISK Unlock Forecast - 30 Days FREE Trial $1809M 30.4x x
FPI Unlock Forecast - 30 Days FREE Trial $435M 6.3x 434854.3x
FR Unlock Forecast - 30 Days FREE Trial $7724M 32.6x 2.9x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
FRT Unlock Forecast - 30 Days FREE Trial $8705M 25.1x 2.7x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1730M 5.0x 0.5x
FSP Unlock Forecast - 30 Days FREE Trial $100M -1.9x 0.2x
FVR Unlock Forecast - 30 Days FREE Trial $330M 1175.4x 0.9x
GEDC Unlock Forecast - 30 Days FREE Trial $10M x x
GIPR Unlock Forecast - 30 Days FREE Trial $5M -0.8x 17.0x
GLPI Unlock Forecast - 30 Days FREE Trial $12461M 16.1x 2.7x
GMRE Unlock Forecast - 30 Days FREE Trial $470M 188.2x 1.0x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $322M 128.8x 0.7x
GNL Unlock Forecast - 30 Days FREE Trial $1851M -4.5x 1.1x
GNL-PA Unlock Forecast - 30 Days FREE Trial $5079M x 3.0x
GNL-PB Unlock Forecast - 30 Days FREE Trial $4876M x 2.9x
GNL-PD Unlock Forecast - 30 Days FREE Trial $5425M x 3.2x
GNL-PE Unlock Forecast - 30 Days FREE Trial $5183M x 3.1x
GPMT Unlock Forecast - 30 Days FREE Trial $126M -0.9x 0.2x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $919M x 1.6x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2621M x 3.0x
HHH Unlock Forecast - 30 Days FREE Trial $5035M 42.7x 1.3x
HIW Unlock Forecast - 30 Days FREE Trial $2832M 21.8x 1.2x
HLTC Unlock Forecast - 30 Days FREE Trial $211M x 0.3x
HST Unlock Forecast - 30 Days FREE Trial $12819M 17.4x 1.9x
ICRP Unlock Forecast - 30 Days FREE Trial $74M 24.3x 0.3x
ICR-PA Unlock Forecast - 30 Days FREE Trial $214M 70.2x 0.9x
IHT Unlock Forecast - 30 Days FREE Trial $12M -57.7x 3.1x
ILPT Unlock Forecast - 30 Days FREE Trial $377M -2.3x 0.8x
IMPM Unlock Forecast - 30 Days FREE Trial $1M x x
INN Unlock Forecast - 30 Days FREE Trial $557M 351.7x 0.6x
INN-PE Unlock Forecast - 30 Days FREE Trial $2044M 1290.1x 2.3x
INN-PF Unlock Forecast - 30 Days FREE Trial $2073M 1308.5x 2.4x
INRE Unlock Forecast - 30 Days FREE Trial $379M x 1.1x
IOR Unlock Forecast - 30 Days FREE Trial $76M 18.4x 0.6x
IRM Unlock Forecast - 30 Days FREE Trial $24361M 153.0x -41.7x
IRT Unlock Forecast - 30 Days FREE Trial $4062M 182.3x 1.2x
IVR Unlock Forecast - 30 Days FREE Trial $573M 10.8x 0.7x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1747M 32.8x 2.3x
IVT Unlock Forecast - 30 Days FREE Trial $2253M 19.0x 1.3x
JBGS Unlock Forecast - 30 Days FREE Trial $1024M -11.3x 0.6x
KBSR Unlock Forecast - 30 Days FREE Trial $180M x 0.9x
KIM Unlock Forecast - 30 Days FREE Trial $13883M 23.2x 1.3x
KIM-PL Unlock Forecast - 30 Days FREE Trial $13734M 22.9x 1.3x
KIM-PM Unlock Forecast - 30 Days FREE Trial $13910M 23.2x 1.3x
KIM-PN Unlock Forecast - 30 Days FREE Trial $39481M 65.8x 3.8x
KRC Unlock Forecast - 30 Days FREE Trial $4737M 14.7x 0.9x
KREF Unlock Forecast - 30 Days FREE Trial $581M 952.5x 0.5x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1203M x 1.0x
KRG Unlock Forecast - 30 Days FREE Trial $5119M 48.7x 1.6x
LADR Unlock Forecast - 30 Days FREE Trial $1436M 18.1x 1.0x
LAMR Unlock Forecast - 30 Days FREE Trial $12914M 29.8x 12.5x
LAND Unlock Forecast - 30 Days FREE Trial $326M 33.0x 0.5x
LANDM Unlock Forecast - 30 Days FREE Trial $904M 91.8x 1.4x
LANDO Unlock Forecast - 30 Days FREE Trial $680M 69.0x 1.0x
LANDP Unlock Forecast - 30 Days FREE Trial $678M 68.7x 1.0x
LFT Unlock Forecast - 30 Days FREE Trial $80M 8.1x 0.4x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1066M 108.8x 4.6x
LINE Unlock Forecast - 30 Days FREE Trial $8257M x 1.0x
LOAN Unlock Forecast - 30 Days FREE Trial $56M 10.5x 1.3x
LTC Unlock Forecast - 30 Days FREE Trial $1656M 48.9x 1.7x
LXP Unlock Forecast - 30 Days FREE Trial $14782M 125.9x 7.2x
LXP-PC Unlock Forecast - 30 Days FREE Trial $13901M 118.4x 6.7x
MAA Unlock Forecast - 30 Days FREE Trial $15537M 28.0x 2.7x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6201M 11.2x 1.1x
MAC Unlock Forecast - 30 Days FREE Trial $4765M -64.7x 1.9x
MDRR Unlock Forecast - 30 Days FREE Trial $15M -8.9x 1.5x
MDV Unlock Forecast - 30 Days FREE Trial $173M 122.6x 1.1x
MDV-PA Unlock Forecast - 30 Days FREE Trial $290M 205.5x 1.8x
MFA Unlock Forecast - 30 Days FREE Trial $981M 7.6x 0.5x
MFAN Unlock Forecast - 30 Days FREE Trial $2549M 19.9x 1.4x
MFAO Unlock Forecast - 30 Days FREE Trial $2575M 20.1x 1.4x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2034M 15.8x 1.1x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2361M 18.4x 1.3x
MITN Unlock Forecast - 30 Days FREE Trial $803M 16.2x 1.4x
MITP Unlock Forecast - 30 Days FREE Trial $803M 16.2x 1.4x
MITT Unlock Forecast - 30 Days FREE Trial $267M 5.4x 0.5x
MITT-PA Unlock Forecast - 30 Days FREE Trial $727M 14.6x 1.3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $695M 14.0x 1.2x
MITT-PC Unlock Forecast - 30 Days FREE Trial $792M 15.9x 1.4x
MKZR Unlock Forecast - 30 Days FREE Trial $67M x 1.2x
MPW Unlock Forecast - 30 Days FREE Trial $3030M -1.3x 0.7x
NHI Unlock Forecast - 30 Days FREE Trial $3565M 24.2x 2.4x
NHPAP Unlock Forecast - 30 Days FREE Trial $548M x 0.9x
NHPBP Unlock Forecast - 30 Days FREE Trial $532M x 0.9x
NLCP Unlock Forecast - 30 Days FREE Trial $280M 10.6x 0.7x
NLOP Unlock Forecast - 30 Days FREE Trial $389M x 0.9x
NLY Unlock Forecast - 30 Days FREE Trial $15228M 10.2x 1.0x
NLY-PF Unlock Forecast - 30 Days FREE Trial $17262M 11.5x 1.2x
NLY-PG Unlock Forecast - 30 Days FREE Trial $16911M 11.3x 1.1x
NLY-PI Unlock Forecast - 30 Days FREE Trial $17224M 11.5x 1.2x
NNN Unlock Forecast - 30 Days FREE Trial $7679M 19.6x 1.7x
NREF Unlock Forecast - 30 Days FREE Trial $265M 2.3x 2.0x
NREF-PA Unlock Forecast - 30 Days FREE Trial $422M 3.7x 3.1x
NSA Unlock Forecast - 30 Days FREE Trial $2260M 33.4x 2.3x
NSA-PA Unlock Forecast - 30 Days FREE Trial $1657M 24.5x 1.7x
NSA-PB Unlock Forecast - 30 Days FREE Trial $1631M 24.1x 1.7x
NTST Unlock Forecast - 30 Days FREE Trial $1460M 7892.2x 1.1x
NXDT Unlock Forecast - 30 Days FREE Trial $161M -1.9x 0.2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $661M x 0.9x
NXRT Unlock Forecast - 30 Days FREE Trial $732M 16.6x 2.3x
NYC Unlock Forecast - 30 Days FREE Trial $21M -0.1x 0.3x
O Unlock Forecast - 30 Days FREE Trial $53427M 55.5x 1.4x
OGCP Unlock Forecast - 30 Days FREE Trial $1817M 30.5x x
OLP Unlock Forecast - 30 Days FREE Trial $439M 13.1x 1.4x
ONL Unlock Forecast - 30 Days FREE Trial $118M -2.5x 0.2x
ORC Unlock Forecast - 30 Days FREE Trial $1057M 17.3x 1.0x
OUT Unlock Forecast - 30 Days FREE Trial $3893M 31.4x 7.2x
PCH Unlock Forecast - 30 Days FREE Trial $3130M 48.7x 1.6x
PCOK Unlock Forecast - 30 Days FREE Trial $148M x 0.2x
PEB Unlock Forecast - 30 Days FREE Trial $1284M -21.5x 0.5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2252M x 0.9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2214M x 0.9x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2216M x 0.9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $2062M x 0.8x
PECO Unlock Forecast - 30 Days FREE Trial $4472M 54.6x 2.0x
PGRE Unlock Forecast - 30 Days FREE Trial $1462M -5.8x 0.5x
PINE Unlock Forecast - 30 Days FREE Trial $244M 169.3x 1.1x
PKST Unlock Forecast - 30 Days FREE Trial $532M -3.7x 0.7x
PLD Unlock Forecast - 30 Days FREE Trial $121339M 37.8x 2.3x
PLDGP Unlock Forecast - 30 Days FREE Trial $53863M 16.8x 1.0x
PMT Unlock Forecast - 30 Days FREE Trial $1084M 8.9x 0.6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2091M 17.1x 1.1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2097M 17.2x 1.1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1607M 13.2x 0.9x
PMTU Unlock Forecast - 30 Days FREE Trial $2257M 18.5x 1.2x
PMTV Unlock Forecast - 30 Days FREE Trial $2219M 18.2x 1.2x
PMTW Unlock Forecast - 30 Days FREE Trial $2203M 18.1x 1.2x
PSA Unlock Forecast - 30 Days FREE Trial $47916M 25.3x 5.2x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3758M 2.0x 0.4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3634M 1.9x 0.4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4123M 2.2x 0.4x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3430M 1.8x 0.4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3351M 1.8x 0.4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3360M 1.8x 0.4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3325M 1.8x 0.4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $2964M 1.6x 0.3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2723M 1.4x 0.3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2790M 1.5x 0.3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $2843M 1.5x 0.3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2823M 1.5x 0.3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2845M 1.5x 0.3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $2873M 1.5x 0.3x
PSTL Unlock Forecast - 30 Days FREE Trial $368M 26.2x 1.3x
PW Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.6x
PW-PA Unlock Forecast - 30 Days FREE Trial $17M x 2.7x
RC Unlock Forecast - 30 Days FREE Trial $387M -13.0x 0.2x
RCB Unlock Forecast - 30 Days FREE Trial $3991M -44.3x 2.3x
RCC Unlock Forecast - 30 Days FREE Trial $4028M -45.2x 2.3x
RCD Unlock Forecast - 30 Days FREE Trial $3578M x 2.0x
RC-PC Unlock Forecast - 30 Days FREE Trial $2309M x 1.3x
RC-PE Unlock Forecast - 30 Days FREE Trial $2324M x 1.3x
REFI Unlock Forecast - 30 Days FREE Trial $284M 7.9x 0.9x
REG Unlock Forecast - 30 Days FREE Trial $12437M 38.3x 1.8x
REGCO Unlock Forecast - 30 Days FREE Trial $4125M 12.7x 0.6x
REGCP Unlock Forecast - 30 Days FREE Trial $4304M 13.2x 0.6x
REXR Unlock Forecast - 30 Days FREE Trial $9575M 28.2x 1.1x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5322M 15.7x 0.6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5071M 14.9x 0.6x
RHP Unlock Forecast - 30 Days FREE Trial $6225M 25.7x 8.2x
RITM Unlock Forecast - 30 Days FREE Trial $6201M 6.9x 0.7x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14068M 15.6x 1.7x
RITM-PB Unlock Forecast - 30 Days FREE Trial $13949M 15.5x 1.6x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13622M 15.1x 1.6x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13600M 15.1x 1.6x
RLJ Unlock Forecast - 30 Days FREE Trial $1157M 34.6x 0.5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3817M 114.1x 1.7x
RPT Unlock Forecast - 30 Days FREE Trial $127M 110.9x 0.4x
RPT-PC Unlock Forecast - 30 Days FREE Trial $1140M 997.6x 3.9x
RWT Unlock Forecast - 30 Days FREE Trial $710M 31.3x 0.7x
RWTN Unlock Forecast - 30 Days FREE Trial $3141M x 3.1x
RWTO Unlock Forecast - 30 Days FREE Trial $3169M x 3.2x
RWTP Unlock Forecast - 30 Days FREE Trial $3132M x 3.1x
RWT-PA Unlock Forecast - 30 Days FREE Trial $3138M x 3.1x
SACH Unlock Forecast - 30 Days FREE Trial $55M 14.5x 0.3x
SACH-PA Unlock Forecast - 30 Days FREE Trial $874M 230.7x 5.0x
SAFE Unlock Forecast - 30 Days FREE Trial $1012M 9.0x 0.4x
SBAC Unlock Forecast - 30 Days FREE Trial $20621M 24.1x -5.1x
SBRA Unlock Forecast - 30 Days FREE Trial $4788M 27.3x 1.7x
SCCC Unlock Forecast - 30 Days FREE Trial $1192M 361.5x 6.8x
SCCD Unlock Forecast - 30 Days FREE Trial $1158M 305.8x 6.6x
SCCE Unlock Forecast - 30 Days FREE Trial $1110M 293.1x 6.3x
SCCF Unlock Forecast - 30 Days FREE Trial $1114M 294.1x 6.3x
SCCG Unlock Forecast - 30 Days FREE Trial $1107M 292.3x 6.3x
SELF Unlock Forecast - 30 Days FREE Trial $57M 31.6x 1.2x
SEVN Unlock Forecast - 30 Days FREE Trial $145M 9.4x 0.6x
SILA Unlock Forecast - 30 Days FREE Trial $1257M 32.0x 0.9x
SITC Unlock Forecast - 30 Days FREE Trial $384M 10.2x 1.3x
SKT Unlock Forecast - 30 Days FREE Trial $3914M 48.1x 5.6x
SLG Unlock Forecast - 30 Days FREE Trial $3238M 190.3x 0.9x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1499M 88.1x 0.4x
SMA Unlock Forecast - 30 Days FREE Trial $1007M x 0.8x
SOHO Unlock Forecast - 30 Days FREE Trial $45M -1.4x 1.2x
SOHOB Unlock Forecast - 30 Days FREE Trial $344M -21.4x 9.4x
SOHON Unlock Forecast - 30 Days FREE Trial $311M -21.8x 8.5x
SOHOO Unlock Forecast - 30 Days FREE Trial $353M -25.6x 9.6x
SPG Unlock Forecast - 30 Days FREE Trial $60119M 26.8x 25.6x
SPG-PJ Unlock Forecast - 30 Days FREE Trial $17888M 8.0x 7.6x
SQFT Unlock Forecast - 30 Days FREE Trial $38M 1.2x 1.1x
SQFTP Unlock Forecast - 30 Days FREE Trial $139M 24.7x 3.9x
STAG Unlock Forecast - 30 Days FREE Trial $7014M 29.1x 2.1x
STLY Unlock Forecast - 30 Days FREE Trial $26M 15.5x 0.6x
STRW Unlock Forecast - 30 Days FREE Trial $172M 24.5x 12.1x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0.4x
STWD Unlock Forecast - 30 Days FREE Trial $6855M 18.7x 1.0x
SUI Unlock Forecast - 30 Days FREE Trial $15314M 14.6x 2.2x
SUNS Unlock Forecast - 30 Days FREE Trial $138M 11.2x 0.8x
SVC Unlock Forecast - 30 Days FREE Trial $319M -2.2x 0.5x
TCI Unlock Forecast - 30 Days FREE Trial $431M 76.8x 0.5x
TFSA Unlock Forecast - 30 Days FREE Trial $205M x 0.0x
TPTA Unlock Forecast - 30 Days FREE Trial $579M x 3.6x
TRTX Unlock Forecast - 30 Days FREE Trial $715M 10.7x 0.7x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1481M 22.1x 1.4x
TWO Unlock Forecast - 30 Days FREE Trial $1034M 14.6x 0.4x
TWOD Unlock Forecast - 30 Days FREE Trial $2677M 37.9x 1.1x
TWO-PA Unlock Forecast - 30 Days FREE Trial $2437M 34.5x 1.0x
TWO-PB Unlock Forecast - 30 Days FREE Trial $2396M 33.9x 1.0x
TWO-PC Unlock Forecast - 30 Days FREE Trial $2501M 35.4x 1.0x
UDR Unlock Forecast - 30 Days FREE Trial $11838M 79.1x 3.6x
UHT Unlock Forecast - 30 Days FREE Trial $587M 32.7x 3.7x
UMH Unlock Forecast - 30 Days FREE Trial $1358M 50.5x 1.5x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1881M 70.0x 2.0x
VICI Unlock Forecast - 30 Days FREE Trial $30568M 11.0x 1.1x
VNO Unlock Forecast - 30 Days FREE Trial $6682M 7.4x 1.1x
VNO-PL Unlock Forecast - 30 Days FREE Trial $3463M 3.8x 0.6x
VNO-PM Unlock Forecast - 30 Days FREE Trial $3355M 3.7x 0.6x
VNO-PN Unlock Forecast - 30 Days FREE Trial $3334M 3.7x 0.6x
VNO-PO Unlock Forecast - 30 Days FREE Trial $2839M 3.1x 0.5x
VNORP Unlock Forecast - 30 Days FREE Trial $13223M 14.6x 2.2x
VRE Unlock Forecast - 30 Days FREE Trial $1386M 22.0x 1.2x
VTR Unlock Forecast - 30 Days FREE Trial $36950M 155.2x 3.0x
WELL Unlock Forecast - 30 Days FREE Trial $130302M 135.7x 3.4x
WHLR Unlock Forecast - 30 Days FREE Trial $3M 0.1x -0.7x
WHLRD Unlock Forecast - 30 Days FREE Trial $36M 0.8x -4.8x
WHLRL Unlock Forecast - 30 Days FREE Trial $85M 1.8x -21.2x
WHLRP Unlock Forecast - 30 Days FREE Trial $4M 0.1x -0.6x
WPC Unlock Forecast - 30 Days FREE Trial $14409M 39.5x 1.8x
WSR Unlock Forecast - 30 Days FREE Trial $690M 15.5x 1.6x
WY Unlock Forecast - 30 Days FREE Trial $16832M 50.9x 1.8x

Frequently Asked Questions - BrightSpire Capital, Inc. Stock Forecast

How accurate are BrightSpire Capital, Inc. stock predictions?

Our AI model shows a 3% Spearman correlation coefficient for BRSP predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence BrightSpire Capital, Inc. stock price forecasts?

Our analysis considers BrightSpire Capital, Inc.'s financial metrics, Real Estate & Construction sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is BrightSpire Capital, Inc. a good investment in 2025?

Based on our AI analysis, BrightSpire Capital, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are BrightSpire Capital, Inc. forecasts updated?

BrightSpire Capital, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced BrightSpire Capital, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for BrightSpire Capital, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...